December 1, 2022 BioFluidica is excited about next week’s San Antonio Breast Cancer Symposium (SABCS). We want to share our enthusiasm with you about LiquidScan exosome and [Read More...]
November 1 - 5 BioFluidica attended the Association for Molecular Pathology (AMP) 2022 Annual Meeting and Expo this week, showcasing their LiquidScan technology. AMP is the leading [Read More...]
September 28, 2022 The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) has been found to be highly infectious resulting in the need [Read More...]
By Jamie Reno, June 15, 2022 BioFluidica presented its LiquidScan, a microfluidic chip that searches a blood sample for rare biomarkers such as CTCs (circulating tumor cells), cell-free [Read More...]
June 3 - 7, 2022 BioFluidica attended the ASCO Annual Meeting, exhibiting at Booth 21160 and presenting a poster abstract about the results of a patient sample [Read More...]
April 5, 2022 SAN DIEGO - Biofluidica today announced they will be introducing their new biomarker isolation platform, LiquidScan™, at the annual AACR Conference on April 10-13 [Read More...]
By LabPulse.com staff writers, February 10, 2022 February 10, 2022 -- Biotechnology company BioFluidica raised more than $6 million in a recent round of financing. The San Diego-based [Read More...]